Overview
Clinical Meaning
Liver function tests (LFTs) comprise a panel of serum biomarkers that reflect hepatocellular integrity, biliary function, and synthetic capacity of the liver.
FNP
FNP
Liver function tests (LFTs) comprise a panel of serum biomarkers that reflect hepatocellular integrity, biliary function, and synthetic capacity of the liver. Understanding the patterns of elevation guides the NP toward accurate differential diagnosis and appropriate workup. Hepatocellular enzymes: Alanine aminotransferase (ALT) is predominantly found in hepatocytes and is the most specific marker of hepatocellular injury. Aspartate aminotransferase (AST) is found in hepatocytes, cardiac muscle, skeletal muscle, kidney, and brain, making it less liver-specific. Both are released into the serum when hepatocyte membranes are damaged. The AST:ALT ratio provides diagnostic information: ratio <1 in most hepatitis (viral, drug-induced); ratio >2:1 strongly suggests alcoholic liver disease (alcohol preferentially damages mitochondria where AST is concentrated, and chronic alcohol use depletes pyridoxal-5-phosphate [vitamin B6] needed for ALT synthesis); ratio >3:1 is highly suggestive of alcoholic hepatitis. Cholestatic enzymes: Alkaline phosphatase (ALP) is present in bile duct epithelium, bone, placenta, and intestine. Gamma-glutamyl transferase (GGT) is found in bile duct epithelium and hepatocytes. Elevation of both ALP and GGT together indicates hepatobiliary origin (cholestatic pattern). Isolated ALP elevation without GGT elevation suggests bone origin...
Unlock full lesson + practice questions
4 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this FNP pathway. You can still explore topic-filtered questions from the bank hubs below.